Paige C White, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1340 Broad Ave, Suite 210, Gulfport, MS 39501 Phone: 228-575-1600 Fax: 228-575-1603 |
Dr. William Milton Hughes V, MD Urology Medicare: Medicare Enrolled Practice Location: 15190 Community Rd Ste 300, Gulfport, MS 39503 Phone: 251-433-1895 |
Dr. David Champ Weeks, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1340 Broad Ave, Suite 210, Gulfport, MS 39501 Phone: 228-575-1600 Fax: 228-575-1603 |
Dr. Arthur M Matthews Jr., MD Urology Medicare: Accepting Medicare Assignments Practice Location: 15190 Community Rd, Suite 370, Gulfport, MS 39503 Phone: 228-831-9699 Fax: 882-831-3908 |
Jacob N Jorns, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1340 Broad Ave Ste 210, Gulfport, MS 39501 Phone: 228-575-1600 |
News Archive
Advocacy for Patients with Chronic Illness, Inc., one of the only organizations in America that files free insurance appeals for consumers with chronic illness nationwide - today filed comments with the United States Department of Health and Human Services, Department of Labor, and Internal Revenue Service both complimenting the Agencies for "the thoughtful approach taken by the Agencies in formulating these complex rules," and suggesting numerous improvements that should be made.
Women are more prone to the development of autoimmune diseases. The female hormone estrogen is likely to affect the immune system.
In his latest Kaiser Health News column, Timothy Jost writes that the development of this draft rule is not a contest with winners and losers, but an effort to create a framework to press insurers to spend less money on bureaucracy and more on health care in a way that benefits consumers and keeps insurance markets viable (9/30).
Researchers from Boston University School of Medicine (BUSM) have discovered a new gene therapy that may prevent the progression of emphysema. The study, which appears on-line in the Journal of Clinical Investigation, describes a method to express therapeutic genes in lung tissue for a lifetime after only a single treatment.
The Sonova Group achieved sales of CHF 709.2 million in the first half of 2009/10, representing year-on-year sales growth of 18.2% in Swiss francs. Organic sales growth of 17.5% in local currencies was well above the estimated market growth of around 3% in units. Numerous smaller acquisitions in Europe, Asia/Pacific and North America contributed a total of 4.3% to sales growth.
› Verified 4 days ago